VetFamily establishes presence in Australia through acquisition of IVA

Jun 11 2021

VetFamily establishes presence in Australia through acquisition of IVA

VetFamily, the operating company within Vimian’s Veterinary Services segment, has signed an agreement to acquire Independent Vets of Australia (“IVA”), a provider of procurement and support services to more than 115 member clinics in Australia.

The acquisition brings together two complementary organisations, each dedicated to supporting independent veterinary clinics and committed to empowering clinic owners and veterinarians to run better businesses and improving enhanced animal care. For IVA, with annual revenues of approximately EUR 1 million, VetFamily’s international scale and portfolio of solutions is expected to provide additional benefits to the IVA members over time. VetFamily, which has continuously expanded its geographic reach over the last few years, sees IVA as a great fit as it takes the step into the Australian market.

Mikael Sjögren, CEO of VetFamily comments:
“VetFamily’s focus is to help veterinary clinics improve today but also prepare our members for tomorrow, as the veterinary market is evolving quickly. The focus on working for the independent clinics’ long-term success is something we share with IVA so we are very excited to work together to develop our support to IVA’s members even further in the future”, says Mikael Sjögren, CEO of VetFamily.

VetFamily is a membership-based service platform for veterinary clinics, with more than 2,600 members. The company offers procurement and tech-enabled services, such as preventive care plans, clinic improvement services, online marketing and education, as well as providing a vibrant community for vet clinics.

For further information, please contact:

Mikael Sjögren
CEO of VetFamily
+46 730 50 07 37

Fredrik Sätterström
Head of Investor Relations at Vimian
+46 705 10 10 22

About Vimian
Vimian is a fast-growing and profitable company targeting global niches within animal health, characterised by significant unmet needs and sustainable above-market growth potential. Today, the Group covers four essential and rapidly evolving segments of animal health – Specialty Pharma, Diagnostics, Veterinary Services and MedTech. By partnering with exceptional entrepreneurs and management teams within selected niches of animal health, Vimian aims to create an ecosystem of category leaders, innovators, and entrepreneurs with the unique ability to combine the strengths and capabilities of a global group with the intimacy, speed, and creativity of an owner-led business. Headquartered in Stockholm, Sweden, Vimian and its over 400 employees offer a diversified portfolio of products, services and solutions, including over 13,000 SKUs protected by over 100 patents, to more than 15,000 veterinary clinics and labs in over 150 countries.